BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8133017)

  • 21. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury.
    Yoshiyama M; Kim S; Yamagishi H; Omura T; Tani T; Yanagi S; Toda I; Teragaki M; Akioka K; Takeuchi K
    Am Heart J; 1994 Jul; 128(1):1-6. PubMed ID: 8017262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The imperatorin derivative OW1, a new vasoactive compound, inhibits VSMC proliferation and extracellular matrix hyperplasia.
    Zhou N; Zhang Y; Wang T; He J; He H; He L
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):125-33. PubMed ID: 25727310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypotensive activity of TCV-116, a newly developed angiotensin II receptor antagonist, in spontaneously hypertensive rats.
    Mizuno K; Niimura S; Tani M; Saito I; Sanada H; Takahashi M; Okazaki K; Yamaguchi M; Fukuchi S
    Life Sci; 1992; 51(20):PL183-7. PubMed ID: 1435062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats.
    Bennett MA; Thurston H
    Clin Sci (Lond); 1996 Jan; 90(1):21-9. PubMed ID: 8697701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA
    Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different effects of antihypertensive agents on cardiac and vascular hypertrophy in the transgenic rat line TGR(mRen2)27.
    Brosnan MJ; Devlin AM; Clark JS; Mullins JJ; Dominiczak AF
    Am J Hypertens; 1999 Jul; 12(7):724-31. PubMed ID: 10411370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the non-peptide angiotensin II receptor antagonist TCV-116 on systemic and renal hemodynamics in dogs with renal hypertension.
    Ito K; Shiomi M; Kito G
    Hypertens Res; 1995 Mar; 18(1):69-75. PubMed ID: 7584913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy.
    Mukawa H; Toki Y; Shimauchi A; Matsui H; Morishima I; Okumura K; Ito T; Hayakawa T
    J Hypertens; 1997 Sep; 15(9):1027-32. PubMed ID: 9321751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin converting enzyme inhibitor normalizes vascular natriuretic peptide type A receptor gene expression via bradykinin-dependent mechanism in hypertensive rats.
    Yoshimoto T; Naruse K; Shionoya K; Tanaka M; Seki T; Hagiwara H; Hirose S; Kuen LS; Demura H; Naruse M; Muraki T
    Biochem Biophys Res Commun; 1996 Jan; 218(1):50-3. PubMed ID: 8573174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.
    Iimura O; Shimamoto K; Matsuda K; Masuda A; Takizawa H; Higashiura K; Miyazaki Y; Hirata A; Ura N; Nakagawa M
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):353-7. PubMed ID: 7619347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Dominiczak AF; Devlin AM; Lee WK; Anderson NH; Bohr DF; Reid JL
    Hypertension; 1996 Mar; 27(3 Pt 2):752-9. PubMed ID: 8613236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal angiotensin II receptor regulation and renin-angiotensin system inhibition in one-kidney, one clip hypertensive rats.
    Amiri F; Haddad G; Garcia R
    J Hypertens; 1999 Feb; 17(2):279-86. PubMed ID: 10067798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
    Matsumoto K; Morishita R; Moriguchi A; Tomita N; Yo Y; Nishii T; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats.
    Yamagishi H; Kim S; Nishikimi T; Takeuchi K; Takeda T
    J Mol Cell Cardiol; 1993 Nov; 25(11):1369-80. PubMed ID: 8301670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
    Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
    J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells.
    Koh E; Morimoto S; Tomita J; Rakugi H; Jiang B; Inoue T; Nabata T; Fukuo K; Ogihara T
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):175-9. PubMed ID: 7511744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.